|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000169696 |
Summary for ASPSCR1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000169696 | Gene symbol | ASPSCR1 |
| Gene name | ASPSCR1 tether for SLC2A4, UBX domain containing | |
| HGNC | 13825 | |
| Entrez ID | 79058 | |
| Gene type | protein_coding | |
| Synonyms | ASPSCR1|ASPS|ASPL|UBXD9|UBXN9|TUG | |
| UniProtAcc | Q9BZE9 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ASPSCR1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ASPSCR1 | 2.40e+03 | 1.26e+00 | 2.70e-01 | 4.65e+00 | 3.33e-06 | 2.25e-05 | BLCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ASPSCR1 | 1.96e+03 | 1.10e+00 | 7.82e-02 | 1.41e+01 | 3.63e-45 | 3.13e-44 | BRCA |
| ASPSCR1 | 1.90e+03 | 1.41e+00 | 3.48e-01 | 4.06e+00 | 4.82e-05 | 2.55e-04 | READ |
Top |
Sex-biased somatic mutation for ASPSCR1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ASPSCR1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| THCA | cg24392479 | chr17:81976994 | CGI:chr17:81977261-81978175 | promoter,gene body | 9.29e-02 | 1.94e-01 | -5.12e+00 | 3.07e-07 | 1.42e-05 | -1.02e-01 |
| LUSC | cg07104895 | chr17:81978623 | CGI:chr17:81977261-81978175 | UTR,promoter,exon,gene body | 8.83e-01 | 9.83e-01 | -2.19e+00 | 2.85e-02 | 3.17e-02 | -1.00e-01 |
| COAD | cg07104895 | chr17:81978623 | CGI:chr17:81977261-81978175 | UTR,promoter,exon,gene body | 6.08e-01 | 9.34e-01 | -3.24e+00 | 1.19e-03 | 2.59e-03 | -3.26e-01 |
| LIHC | cg19506201 | chr17:81978685 | CGI:chr17:81977261-81978175 | UTR,promoter,exon,gene body | 4.55e-01 | 7.38e-01 | -5.85e+00 | 4.96e-09 | 4.54e-08 | -2.83e-01 |
| CHOL | cg07104895 | chr17:81978623 | CGI:chr17:81977261-81978175 | UTR,promoter,exon,gene body | 8.68e-01 | 7.25e-01 | 2.36e+00 | 1.83e-02 | 2.92e-02 | 1.44e-01 |
| CHOL | cg19506201 | chr17:81978685 | CGI:chr17:81977261-81978175 | UTR,promoter,exon,gene body | 8.52e-01 | 7.13e-01 | 2.36e+00 | 1.83e-02 | 2.92e-02 | 1.39e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for ASPSCR1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ASPSCR1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ASPSCR1 |
| TFs related to ASPSCR1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | PLAGL2 | ASPSCR1 | 3.64e+00 | 1.23e-02 | 4.79e+00 | 9.82e-01 | Female-biased |
| ASPSCR1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for ASPSCR1 |
| RBPs related to ES in ASPSCR1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | HNRNPH2 | exon_skip_284535 | 6.04e+00 | 2.14e-03 | 6.64e+00 | 9.81e-01 | Female-biased |
| UVM | SRSF1 | exon_skip_284539 | 8.93e+00 | 9.93e-01 | 8.53e+00 | 2.62e-03 | Male-biased |
| ESCA | HNRNPH2 | exon_skip_284535 | 6.63e+00 | 4.15e-04 | 7.51e+00 | 9.90e-01 | Female-biased |
| GBM | SRSF1 | exon_skip_284539 | 8.72e+00 | 1.15e-02 | 9.05e+00 | 9.84e-01 | Female-biased |
| SARC | ZC3H10 | exon_skip_284527 | 6.99e+00 | 9.83e-01 | 6.47e+00 | 2.61e-03 | Male-biased |
| ASPSCR1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs113255352 | chr17:77081667:C:T | - | 0.141105360773353 | 0.0133547481937311 | HNSC | Female-baised eQTL |
| rs111625906 | chr17:77081597:A:G | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs113579577 | chr17:77081866:A:G | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs73374683 | chr17:77082078:C:T | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs73374687 | chr17:77082152:A:C | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs75546118 | chr17:77082209:C:A | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs73374689 | chr17:77082466:A:G | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs16969648 | chr17:77082586:A:G | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs77508841 | chr17:77082602:T:C | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs112433423 | chr17:77082751:A:G | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs113961529 | chr17:77083403:G:T | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs73374698 | chr17:77083472:G:A | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs73374700 | chr17:77083530:G:T | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs73374701 | chr17:77083867:A:G | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs73376303 | chr17:77084000:G:A | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs73376306 | chr17:77084157:C:T | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs111673690 | chr17:77084735:G:A | - | 0.126730271337888 | 0.0358500512205941 | HNSC | Female-baised eQTL |
| rs930297 | chr17:75408456:C:T | - | -0.0844093522655486 | 0.00993294270802389 | STAD | Female-baised eQTL |
| rs72844183 | chr17:73495673:C:T | - | 0.0980541325073506 | 0.0154575248604426 | STAD | Female-baised eQTL |
| rs17185043 | chr17:73496589:C:T | - | 0.0980541325073506 | 0.0154575248604426 | STAD | Female-baised eQTL |
| rs12452077 | chr17:82613819:C:T | - | 0.114624435852329 | 0.0169296370196045 | STAD | Female-baised eQTL |
| rs74962425 | chr17:82616739:G:C | - | 0.163647124071536 | 0.0231457442945901 | STAD | Female-baised eQTL |
| rs12150313 | chr17:82610084:T:G | - | 0.163208846870412 | 0.0241516190594425 | STAD | Female-baised eQTL |
| rs1037260 | chr17:73161126:G:T | - | -0.179221609940671 | 0.000348509053477679 | BLCA | Female-baised eQTL |
| rs16977050 | chr17:72052762:A:G | - | 0.213011256681083 | 0.000879891663031636 | BLCA | Female-baised eQTL |
| rs7216891 | chr17:78896581:C:T | - | 0.140127928668755 | 0.0165164049810543 | BLCA | Female-baised eQTL |
| rs77351634 | chr17:76744735:A:G | - | 0.160282214078816 | 0.0231248452970727 | BLCA | Female-baised eQTL |
| rs12601555 | chr17:73540863:C:T | - | 0.161275806597176 | 0.0333618721515176 | BLCA | Female-baised eQTL |
| rs73996951 | chr17:72032415:C:T | - | 0.123547222727705 | 0.0338900977867209 | BLCA | Female-baised eQTL |
| rs73996952 | chr17:72033043:T:C | - | 0.123547222727705 | 0.0338900977867209 | BLCA | Female-baised eQTL |
| rs9911193 | chr17:72051584:T:C | - | 0.133036473851417 | 0.0341776943675297 | BLCA | Female-baised eQTL |
| rs2661601 | chr17:73705994:G:A | - | 0.128152465056311 | 0.0403711473873513 | BLCA | Female-baised eQTL |
| rs9916207 | chr17:72036910:G:A | - | 0.118416453803706 | 0.0452087818991521 | BLCA | Female-baised eQTL |
| rs9896227 | chr17:73778382:T:C | - | 0.0524608183079498 | 0.00530830230533161 | LUAD | Female-baised eQTL |
| rs7215218 | chr17:73779436:T:G | - | 0.0522445484876762 | 0.00619494502778088 | LUAD | Female-baised eQTL |
| rs9896656 | chr17:73778509:T:C | - | 0.0466891369883714 | 0.00768909405710474 | LUAD | Female-baised eQTL |
| rs7215385 | chr17:73779556:T:G | - | 0.0469420514381647 | 0.00769401750023549 | LUAD | Female-baised eQTL |
| rs35769662 | chr17:79340029:C:T | - | 0.0689786747797427 | 0.0308005826795416 | COAD | Female-baised eQTL |
| rs34872009 | chr17:79340069:C:A | - | 0.0689786747797427 | 0.0308005826795416 | COAD | Female-baised eQTL |
| rs34745304 | chr17:79340111:G:A | - | 0.0689786747797427 | 0.0308005826795416 | COAD | Female-baised eQTL |
| rs35105443 | chr17:79340427:C:T | - | 0.0689786747797427 | 0.0308005826795416 | COAD | Female-baised eQTL |
| rs35647708 | chr17:79340409:A:G | - | 0.0686407472229751 | 0.0340145042966405 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12451543 | chr17:76857286:G:A | - | 0.153855049694751 | 0.00976119541646567 | PAAD | Male-baised eQTL |
| rs4969005 | chr17:73024083:T:C | - | -0.0490319662086583 | 0.0323419633298306 | HNSC | Male-baised eQTL |
| rs7224056 | chr17:72581887:T:A | - | 0.0765664017600146 | 0.00918064307167724 | STAD | Male-baised eQTL |
| rs56140816 | chr17:75964396:A:G | - | 0.0368010195958372 | 0.0332715331595022 | BLCA | Male-baised eQTL |
| rs55724872 | chr17:75964471:G:A | - | 0.0368010195958372 | 0.0332715331595022 | BLCA | Male-baised eQTL |
| rs73357507 | chr17:75964910:C:T | - | 0.0368010195958372 | 0.0332715331595022 | BLCA | Male-baised eQTL |
| rs56188825 | chr17:75968133:G:C | - | 0.0368010195958372 | 0.0332715331595022 | BLCA | Male-baised eQTL |
| rs9635661 | chr17:75969456:G:A | - | 0.0368010195958372 | 0.0332715331595022 | BLCA | Male-baised eQTL |
| rs2898586 | chr17:75960802:G:A | - | 0.0367942932600174 | 0.033422702503401 | BLCA | Male-baised eQTL |
| rs57278170 | chr17:75965905:A:G | - | 0.0362266519734125 | 0.0359655510794355 | BLCA | Male-baised eQTL |
| rs73355734 | chr17:75959606:G:T | - | 0.036090868614574 | 0.0374640992150647 | BLCA | Male-baised eQTL |
| rs55752445 | chr17:74773291:G:A | - | 0.0660541677516868 | 0.0122808444835448 | COAD | Male-baised eQTL |
| rs3088029 | chr17:74770652:G:A | - | 0.0633208030478654 | 0.0342338445656768 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg05636603 | |
| Position to Gene: gene | |
| Male Effect: -0.445547668142741 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg11511084 | |
| Position to Gene: gene | |
| Male Effect: -0.445547668142741 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg10624462 | |
| Position to Gene: gene | |
| Male Effect: -0.445292027321835 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg10080728 | |
| Position to Gene: gene | |
| Male Effect: -0.191063216808945 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg05277504 | |
| Position to Gene: gene | |
| Male Effect: -0.426045992498138 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg08091666 | |
| Position to Gene: gene | |
| Male Effect: -0.426045992498138 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg05478824 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.426045992498138 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg23928512 | |
| Position to Gene: gene | |
| Male Effect: -0.426045992498138 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg19506201 | |
| Position to Gene: gene,exon,promoter,UTR | |
| Male Effect: -0.409386428040123 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg11511084 | |
| Position to Gene: gene | |
| Male Effect: -0.409386428040123 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg20901787 | |
| Position to Gene: gene,exon,promoter,UTR | |
| Male Effect: -0.409339536824598 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg07104895 | |
| Position to Gene: gene,exon,promoter,UTR | |
| Male Effect: -0.409339536824598 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg07093539 | |
| Position to Gene: gene | |
| Male Effect: -0.409339536824598 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg05636603 | |
| Position to Gene: gene | |
| Male Effect: -0.409339536824598 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg01523772 | |
| Position to Gene: gene | |
| Male Effect: -0.409339536824598 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg22949575 | |
| Position to Gene: gene | |
| Male Effect: -0.288828631237649 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg06105699 | |
| Position to Gene: gene,exon | |
| Male Effect: -0.156198773327911 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg19506201 | |
| Position to Gene: gene,exon,promoter,UTR | |
| Male Effect: -0.191319647439557 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg22949575 | |
| Position to Gene: gene | |
| Male Effect: -0.191319647439557 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg05636603 | |
| Position to Gene: gene | |
| Male Effect: -0.191319647439557 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg11511084 | |
| Position to Gene: gene | |
| Male Effect: -0.191319647439557 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg23135546 | |
| Position to Gene: gene | |
| Male Effect: -0.191319647439557 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg23632389 | |
| Position to Gene: gene,exon,CDS,UTR | |
| Male Effect: -0.191319647439557 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg05478824 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.191319647439557 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg23632389 | |
| Position to Gene: gene,exon,CDS,UTR | |
| Male Effect: - | |
| Female Effect: -0.26625592389767 | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg10624462 | |
| Position to Gene: gene | |
| Male Effect: -0.466350957262753 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg05636603 | |
| Position to Gene: gene | |
| Male Effect: -0.131674503328973 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg11511084 | |
| Position to Gene: gene | |
| Male Effect: -0.4943088209579 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg20287434 | |
| Position to Gene: gene | |
| Male Effect: -0.4943088209579 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg05478824 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.4943088209579 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg06105699 | |
| Position to Gene: gene,exon | |
| Male Effect: -0.105592171480905 | |
| Female Effect: - | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg19506201 | |
| Position to Gene: gene,exon,promoter,UTR | |
| Male Effect: - | |
| Female Effect: -0.415669774599056 | |
 | Gene ID: ENSG00000169696 |
| CpG Site: cg04817870 | |
| Position to Gene: gene,exon | |
| Male Effect: - | |
| Female Effect: -0.167441446732945 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg05636603 | chr17:81991387 | gene | -0.445547668142741 | 2.25583899974275e-19 | -0.8001055124305707 | 4.975201440134803e-23 | PAAD |
| cg11511084 | chr17:81992490 | gene | -0.445547668142741 | 2.25583899974275e-19 | -0.8001055124305707 | 4.975201440134803e-23 | PAAD |
| cg10624462 | chr17:82000440 | gene | -0.445292027321835 | 2.46968768440971e-19 | -0.8006932225709076 | 7.356692739010229e-23 | PAAD |
| cg10080728 | chr17:81991841 | gene | -0.191063216808945 | 6.25734926904505e-08 | -0.5879637139729847 | 1.9478187247649128e-10 | PAAD |
| cg05277504 | chr17:82003738 | gene | -0.426045992498138 | 8.59354275415602e-17 | -0.6409339711057136 | 1.0689815323806833e-20 | COAD |
| cg08091666 | chr17:82003893 | gene | -0.426045992498138 | 8.59354275415602e-17 | -0.6409339711057136 | 1.0689815323806833e-20 | COAD |
| cg05478824 | chr17:82012259 | gene,exon,CDS | -0.426045992498138 | 8.59354275415602e-17 | -0.6409339711057136 | 1.0689815323806833e-20 | COAD |
| cg23928512 | chr17:82012316 | gene | -0.426045992498138 | 8.59354275415602e-17 | -0.6409339711057136 | 1.0689815323806833e-20 | COAD |
| cg19506201 | chr17:81978685 | gene,exon,promoter,UTR | -0.409386428040123 | 5.14525306656276e-06 | -0.3690050193821803 | 1.4420204293875365e-08 | LUAD |
| cg11511084 | chr17:81992490 | gene | -0.409386428040123 | 5.14525306656276e-06 | -0.3690050193821803 | 1.4420204293875365e-08 | LUAD |
| cg20901787 | chr17:81978601 | gene,exon,promoter,UTR | -0.409339536824598 | 5.15562705478553e-06 | -0.36896941140873757 | 1.3420006929239315e-08 | LUAD |
| cg07104895 | chr17:81978623 | gene,exon,promoter,UTR | -0.409339536824598 | 5.15562705478553e-06 | -0.36896941140873757 | 1.3420006929239315e-08 | LUAD |
| cg07093539 | chr17:81987323 | gene | -0.409339536824598 | 5.15562705478553e-06 | -0.36896941140873757 | 1.3420006929239315e-08 | LUAD |
| cg05636603 | chr17:81991387 | gene | -0.409339536824598 | 5.15562705478553e-06 | -0.36896941140873757 | 1.3420006929239315e-08 | LUAD |
| cg01523772 | chr17:81997295 | gene | -0.409339536824598 | 5.15562705478553e-06 | -0.36896941140873757 | 1.3420006929239315e-08 | LUAD |
| cg22949575 | chr17:81990949 | gene | -0.288828631237649 | 6.93315036582407e-06 | -0.3520334461451444 | 6.614799674125971e-08 | LUAD |
| cg06105699 | chr17:82013560 | gene,exon | -0.156198773327911 | 6.44442904587651e-19 | -0.6002963895097015 | 6.27635453240968e-23 | STAD |
| cg19506201 | chr17:81978685 | gene,exon,promoter,UTR | -0.191319647439557 | 9.02519123227191e-05 | -0.3485979906814968 | 1.1050225607655612e-07 | STAD |
| cg22949575 | chr17:81990949 | gene | -0.191319647439557 | 9.02519123227191e-05 | -0.3485979906814968 | 1.1050225607655612e-07 | STAD |
| cg05636603 | chr17:81991387 | gene | -0.191319647439557 | 9.02519123227191e-05 | -0.3485979906814968 | 1.1050225607655612e-07 | STAD |
| cg11511084 | chr17:81992490 | gene | -0.191319647439557 | 9.02519123227191e-05 | -0.3485979906814968 | 1.1050225607655612e-07 | STAD |
| cg23135546 | chr17:81995150 | gene | -0.191319647439557 | 9.02519123227191e-05 | -0.3485979906814968 | 1.1050225607655612e-07 | STAD |
| cg23632389 | chr17:81996032 | gene,exon,CDS,UTR | -0.191319647439557 | 9.02519123227191e-05 | -0.3485979906814968 | 1.1050225607655612e-07 | STAD |
| cg05478824 | chr17:82012259 | gene,exon,CDS | -0.191319647439557 | 9.02519123227191e-05 | -0.3485979906814968 | 1.1050225607655612e-07 | STAD |
| cg10624462 | chr17:82000440 | gene | -0.466350957262753 | 4.6626315770466e-69 | -0.8367718490981275 | 1.2242722568463256e-73 | LUSC |
| cg05636603 | chr17:81991387 | gene | -0.131674503328973 | 1.59940794636299e-13 | -0.47402477932794684 | 7.227638731140654e-17 | LUSC |
| cg11511084 | chr17:81992490 | gene | -0.4943088209579 | 1.84657368797811e-130 | -0.9331650897239464 | 1.118011730784613e-136 | BLCA |
| cg20287434 | chr17:82000716 | gene | -0.4943088209579 | 1.84657368797811e-130 | -0.9331650897239464 | 1.118011730784613e-136 | BLCA |
| cg05478824 | chr17:82012259 | gene,exon,CDS | -0.4943088209579 | 1.84657368797811e-130 | -0.9331650897239464 | 1.118011730784613e-136 | BLCA |
| cg06105699 | chr17:82013560 | gene,exon | -0.105592171480905 | 3.72909000228274e-19 | -0.5236998943868301 | 7.019001742706535e-23 | BLCA |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg23632389 | chr17:81996032 | gene,exon,CDS,UTR | -0.26625592389767 | 2.11752796900352e-11 | -0.6419004690621339 | 2.12404944364778e-15 | LIHC |
| cg19506201 | chr17:81978685 | gene,exon,promoter,UTR | -0.415669774599056 | 5.38391508411533e-10 | -0.6333188359166037 | 1.4709105288237154e-13 | BLCA |
| cg04817870 | chr17:82005775 | gene,exon | -0.167441446732945 | 5.74826644970758e-09 | -0.5510321165772588 | 5.244336468833663e-12 | HNSC |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ASPSCR1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000169696 | ASPSCR1 | C0206657 | Alveolar Soft Part Sarcoma | 1 | CTD_human |
